SEC Form 4 · accession 0001123292-15-001035
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aron Marc Knickerbocker
Officer — SVP & Chief Business Officer · Director
Period of report
Jul 29, 2015
Accepted (ET)
Jul 31, 2015 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 29, 2015 | M | 339 | $8.49 | A | 84,231 | D | |
| Common Stock | Jul 29, 2015 | M | 354 | $8.49 | A | 84,585 | D | |
| Common Stock | Jul 29, 2015 | M | 15,804 | $5.54 | A | 100,389 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $8.49 | Jul 29, 2015 | M | 339 | D | — | Jul 13, 2021 | Common Stock | 339 | 0 | D |
| Employee Stock Option (right to buy)F2 | $8.49 | Jul 29, 2015 | M | 354 | D | — | Jan 1, 2022 | Common Stock | 354 | 6,290 | D |
| Employee Stock Option (right to buy)F3 | $5.54 | Jul 29, 2015 | M | 15,804 | D | — | Jul 15, 2022 | Common Stock | 15,804 | 30,812 | D |
Explanation of responses
- F1This option is fully vested and immediately exercisable.
- F2This option began vesting on January 2, 2012, at a rate of 1/48th per month.
- F3This option began vesting on July 12, 2012, at a rate of 1/48th per month.